ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition:   Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention:   Sponsor:   Regulus Therapeutics Inc.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials

ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition:   Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention:   Sponsor:   Regulus Therapeutics Inc.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials

ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition:   Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention:   Sponsor:   Regulus Therapeutics Inc.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials

ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition:   Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention:   Sponsor:   Regulus Therapeutics Inc.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials

ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition:   Alport Syndrome Patients With Measured GFR Between 30-75 ml/MinIntervention:   Sponsor:   Regulus Therapeutics Inc.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials